assembly Bill A7689B

2015-2016 Legislative Session

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (6)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 07, 2016 print number 7689b
Jun 07, 2016 amend (t) and recommit to health
Jan 19, 2016 print number 7689a
Jan 19, 2016 amend and recommit to health
Jan 06, 2016 referred to health
May 22, 2015 referred to health

A7689 - Details

See Senate Version of this Bill:
S5553
Current Committee:
Assembly Health
Law Section:
Insurance Law
Laws Affected:
Amd §213, Ins L
Versions Introduced in 2017-2018 Legislative Session:
A2850, S1316

A7689 - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

A7689 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  7689

                       2015-2016 Regular Sessions

                          I N  A S S E M B L Y

                              May 22, 2015
                               ___________

Introduced by M. of A. McDONALD -- read once and referred to the Commit-
  tee on Health

AN  ACT  to  direct the commissioner of health and the superintendent of
  financial services to study and report upon the  impact  of  requiring
  that  certain health insurance plans provide coverage for treatment of
  mitochondrial disease

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The commissioner of health and the superintendent of finan-
cial  services  shall  cause  a  study  to be performed on the impact of
requiring that certain  health  insurance  plans  provide  coverage  for
treatment  of mitochondrial disease. Such study shall include an assess-
ment of the impact of such a requirement on costs to  insurance  provid-
ers, the cost of insurance premiums, and the fiscal impact to the state.
  S  2.  On  or before November 30, 2015, the commissioner of health and
the superintendent  of  financial  services  shall  complete  the  study
conducted  pursuant  to  section  one  of  this act and shall thereafter
deliver a copy of the findings of the study and any  legislative  recom-
mendations  they  deem  to  be  necessary to the governor, the temporary
president of the senate, and the speaker of the assembly.
  S 3. This act shall take effect immediately.




 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11057-02-5

A7689A - Details

See Senate Version of this Bill:
S5553
Current Committee:
Assembly Health
Law Section:
Insurance Law
Laws Affected:
Amd §213, Ins L
Versions Introduced in 2017-2018 Legislative Session:
A2850, S1316

A7689A - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

A7689A - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7689--A

                       2015-2016 Regular Sessions

                          I N  A S S E M B L Y

                              May 22, 2015
                               ___________

Introduced by M. of A. McDONALD -- read once and referred to the Commit-
  tee  on Health -- recommitted to the Committee on Health in accordance
  with Assembly Rule 3, sec. 2 -- committee  discharged,  bill  amended,
  ordered reprinted as amended and recommitted to said committee

AN  ACT  to  direct the commissioner of health and the superintendent of
  financial services to study and report upon the  impact  of  requiring
  that  certain health insurance plans provide coverage for treatment of
  mitochondrial disease

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The commissioner of health and the superintendent of finan-
cial  services  shall  cause  a  study  to be performed on the impact of
requiring that certain  health  insurance  plans  provide  coverage  for
treatment  of mitochondrial disease. Such study shall include an assess-
ment of the impact of such a requirement on costs to  insurance  provid-
ers, the cost of insurance premiums, and the fiscal impact to the state.
  S  2.  On  or before November 30, 2016, the commissioner of health and
the superintendent  of  financial  services  shall  complete  the  study
conducted  pursuant  to  section  one  of  this act and shall thereafter
deliver a copy of the findings of the study and any  legislative  recom-
mendations  they  deem  to  be  necessary to the governor, the temporary
president of the senate, and the speaker of the assembly.
  S 3. This act shall take effect immediately.



 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11057-04-6

A7689B (ACTIVE) - Details

See Senate Version of this Bill:
S5553
Current Committee:
Assembly Health
Law Section:
Insurance Law
Laws Affected:
Amd §213, Ins L
Versions Introduced in 2017-2018 Legislative Session:
A2850, S1316

A7689B (ACTIVE) - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

A7689B (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7689--B

                       2015-2016 Regular Sessions

                          I N  A S S E M B L Y

                              May 22, 2015
                               ___________

Introduced by M. of A. McDONALD -- read once and referred to the Commit-
  tee  on Health -- recommitted to the Committee on Health in accordance
  with Assembly Rule 3, sec. 2 -- committee  discharged,  bill  amended,
  ordered  reprinted  as  amended  and  recommitted to said committee --
  again reported from said committee with amendments, ordered  reprinted
  as amended and recommitted to said committee

AN ACT to amend the insurance law, in relation to directing the New York
  state health care quality and cost containment commission to study and
  report  upon  the  impact  of  requiring that certain health insurance
  plans provide coverage for treatment of mitochondrial disease

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 213 of the insurance law is amended by adding a new
subdivision (e) to read as follows:
  (E)  THE  COMMISSION SHALL CAUSE A STUDY TO BE PERFORMED ON THE IMPACT
OF REQUIRING CERTAIN HEALTH INSURANCE  PLANS  TO  PROVIDE  COVERAGE  FOR
TREATMENT  OF MITOCHONDRIAL DISEASE. SUCH STUDY SHALL INCLUDE AN ASSESS-
MENT OF THE IMPACT OF SUCH A REQUIREMENT ON COSTS TO PROVIDERS, THE COST
OF INSURANCE PREMIUMS, AND THE FISCAL IMPACT TO THE STATE.  THE  COMMIS-
SION  SHALL SUBMIT A REPORT OF THE FINDINGS, CONCLUSIONS AND RECOMMENDA-
TION OF SUCH STUDY, ON OR BEFORE NOVEMBER THIRTIETH, TWO THOUSAND SEVEN-
TEEN, TO THE GOVERNOR,  THE  TEMPORARY  PRESIDENT  OF  THE  SENATE,  THE
SPEAKER OF THE ASSEMBLY, THE CHAIRS OF THE SENATE AND ASSEMBLY INSURANCE
COMMITTEES, AND THE CHAIRS OF THE SENATE AND ASSEMBLY HEALTH COMMITTEES.
  S 2. This act shall take effect immediately.



 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11057-06-6